Global Artificial Intelligence in Precision Medicine Market Size, Status and Forecast 2019-2025

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Artificial intelligence is providing paradigm shift toward precision medicine. Machine learning algorithms are used for genomic sequence and to analyze and draw inferences from the vast amounts of data patients and healthcare institutions recorded in every moment. AI technique is used in precision cardiovascular medicine to understand genotypes and phenotypes in existing diseases, improve the quality of patient care, enable cost-effectiveness, and reduce readmission rates and mortality. In addition, AI helps companies accelerate drug development to reduce costs.
In 2018, the global Artificial Intelligence in Precision Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Artificial Intelligence in Precision Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Artificial Intelligence in Precision Medicine development in United States, Europe and China.

The key players covered in this study
Intel AI
IBM
GE Healthcare
Thermo Fisher Scientific
Qiagen
Berg Health
Medasense Biometrics
...

Market segment by Type, the product can be split into
Hardware
Software
Services

Market segment by Application, split into
Oncology
Neurosciences
Immunology
Respiratory
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Artificial Intelligence in Precision Medicine status, future forecast, growth opportunity, key market and key players.
To present the Artificial Intelligence in Precision Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Artificial Intelligence in Precision Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.